glp 1 pre op A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia Study Challenges Seven-Day Hold on
Description
Wegovy is now available in pill form
The primary outcome was change in HbA1c from randomisation to the end of treatment, secondary outcomes included body weight change

11% clinical fatigue rate peaks week 4 titration

GLP-1 medications do more than weight loss

Eli Lilly Chief Corporate Brand Officer Lina Polimeni on how the brand differentiates itself in the crowded pharma market, including with its GLP-1 medications.
